ArticleFrontiers in medicine2025
The value of multi-phase CT based intratumor and peritumoral radiomics models for evaluating capsular characteristics of parotid pleomorphic adenoma.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Could a multimodal fusion model integrating CT radiomics and systemic inflammatory markers improve preoperative risk stratification of parotid masses? A retrospective exploratory study.Frontiers in immunology · 2026Article
- Deep learning radiomics models based on contrast-enhanced transrectal ultrasound for predicting distant metastasis in rectal cancer.Frontiers in oncology · 2026Article
- A Case of Pleomorphic Adenoma of the Submandibular Gland Radiologically Suspected to be Malignant.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Computed tomography (CT) imaging of parotid pleomorphic adenoma (PA) has been widely reported, nonetheless few reports have estimated the capsule characteristics of PA at length. This study aimed to establish and validate CT-based intratumoral and peritumoral radiomics models to clarify the characteristics between parotid PA with and without complete capsule. Methods: In total, data of 129 patients with PA were randomly assigned to a training and test set at a ratio of 7:3. Quantitative radiomics features of the intratumoral and peritumoral regions of 2 mm and 5 mm on CT images were extracted, and radiomics models of Tumor, External2, External5, Tumor+ External2, and Tumor+External5 were constructed and used to train six different machine learning algorithms. Meanwhile, the prediction performances of different radiomics models (Tumor, External2, External5, Tumor+External2, Tumor+External5) based on single phase (plain, arterial, and venous phase) and multiphase (three-phase combination) were compared. The receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC) were used to evaluate the prediction performance of each model. Results: Among all the established machine learning prediction radiomics models, the model based on a three-phase combination had better prediction performance, and the model using a combination of intratumoral and peritumoral radiomics features achieved a higher AUC than the model with only intratumoral or peritumoral radiomics features, and the Tumor+External2 model based on LR was the optimal model, the AUC of the test set was 0.817 (95% CI = 0.712, 0.847), and its prediction performance was significantly higher ( Conclusion: The intratumoral and peritumoral radiomics model based on multiphasic CT images could accurately predict capsular characteristics of parotid of PA preoperatively, which may help in making treatment strategies before surgery, as well as avoid intraoperative tumor spillage and residuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.